N-Carbamylglutamate in Emergency Management of Hyperammonemia in Neonatal Acute Onset Propionic and Methylmalonic Aciduria

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neonatology

• Publication date

  2009-11-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000255168PMID 19887858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-carbamylglutamate Markedly Enhances Ureagenesis in N-acetylglutamate Deficiency and Propionic Acidemia as Measured by Isotopic Incorporation and Blood Biomarkers

  2008cited by this paper
• Carglumic acid: an additional therapy in the treatment of organic acidurias with hyperammonemia?

  2008cited by this paper
• N-Carbamylglutamate for neonatal hyperammonaemia in propionic acidaemia

  2008cited by this paper
• N-Carbamylglutamate protects patients with decompensated propionicaciduria from hyperammonaemia

  2005cited by this paper
• N-carbamylglutamate enhances ammonia detoxification in a patient with decompensated methylmalonic aciduria.

  2003cited by this paper
• Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation

  2003cited by this paper
• Effects of hyperammonaemia on brain function

  1998cited by this paper
• Disorders of propionate and methylmalonate metabolism

  1982cited by this paper
• Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia.

  1979cited by this paper

• Real-World Experience of Carglumic Acid for Methylmalonic and Propionic Acidurias: An Interim Analysis of the Multicentre Observational PROTECT Study

  2024cites this paper
• Evidence That Long‐Term Treatment Prevents Tissue Oxidative Damage in Patients With Inherited Disorders of the Propionate Pathway

  2024cites this paper
• The significance of N-carbamoylglutamate in ruminant production

  2023cites this paper
• Pathophysiological mechanisms of complications associated with propionic acidemia.

  2023cites this paper
• Case report: Is exchange transfusion a possible treatment for metabolic decompensation in neonates with methylmalonic aciduria in the setting of limited resources?

  2022cites this paper
• Hyperammonemia in Inherited Metabolic Diseases

  2021cites this paper
• Dialytic Therapy of Inborn Errors of Metabolism in Case of Acute Decompensation

  2021cites this paper
• Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial

  2021cites this paper
• Beneficial Effect of N-Carbamylglutamate in a Neonatal Form of Multiple Acyl-CoA Dehydrogenase Deficiency

  2020cites this paper
• Glucagon receptor signaling is not required for L-carbamoyl glutamate and L-citrulline induced ureagenesis in mice.

  2020cites this paper
• Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature

  2020cites this paper
• Short communication: Effects of dietary N-carbamoylglutamate supplementation on the milk amino acid profile and mozzarella cheese quality in mid-lactating dairy cows.

  2020cites this paper
• Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial

  2019cites this paper
• Carglumic acid in hyperammonaemia due to organic acidurias: a profile of its use in the EU

  2019cites this paper
• Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.

  2019cites this paper
• Practical management of organic acidemias

  2019cites this paper
• Nutrition management guideline for propionic acidemia: An evidence- and consensus-based approach.

  2019cites this paper
• Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories

  2018cites this paper
• Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report

  2018cites this paper
• First report of carglumic acid in a patient with citrullinemia type 1 (argininosuccinate synthetase deficiency)

  2018cites this paper
• Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias

  2018cites this paper
• Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder

  2017cites this paper
• Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.

  2017cites this paper
• Clinical trials examining treatments for inborn errors of amino acid metabolism

  2017cites this paper
• Acute Illness Protocol for Organic Acidemias: Methylmalonic Acidemia and Propionic Acidemia

  2017cites this paper
• Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria

  2016cites this paper
• N-Carbamylglutamate Is an Effective Treatment for Acute Neonatal Hyperammonaemia in a Patient with Methylmalonic Aciduria

  2016cites this paper
• Methylmalonic and propionic acidemias: clinical management update

  2016cites this paper
• Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study

  2016cites this paper
• Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders

  2016cites this paper
• Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia

  2014cites this paper
• Liver transplantation for pediatric metabolic disease.

  2014cites this paper
• Stable isotopes in the diagnosis and treatment of inherited hyperammonemia

  2014cites this paper
• Use of carglumic acid in the treatment of hyperammonaemia during metabolic decompensation of patients with propionic acidaemia.

  2013cites this paper
• Clinical outcome of major organic acidemias – A three years follow-up study

  2012cites this paper
• Short-term outcome of propionic aciduria treated at presentation with N-carbamylglutamate: a retrospective review of four patients.

  2012influential citation
• Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia

  2012cites this paper
• Inborn Errors of Metabolism and Brain Involvement - 5 Years Experience from a Tertiary Care Center in South India

  2012cites this paper
• Nutritional and Pharmacological Management during Chemotherapy in a Patient with Propionic Acidaemia and Rhabdomyosarcoma Botryoides.

  2012cites this paper
• Dialytic Therapy of Inborn Errors of Metabolism

  2012cites this paper
• Hyperammonemia in Children: On the Crossroad of Different Disorders

  2012cites this paper
• Branched-chain Organic Acidurias /Acidaemias

  2012cites this paper
• Brain Damage - Bridging Between Basic Research and Clinics

  2012cites this paper
• Hyperammonemia in review: pathophysiology, diagnosis, and treatment

  2012cites this paper
• Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency

  2011cites this paper
• New developments in the treatment of hyperammonemia: emerging use of carglumic acid

  2011cites this paper
• Cobalamin C defect presenting as severe neonatal hyperammonemia

  2011cites this paper
• Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency

  2011cites this paper
• N-carbamylglutamate treatment for acute neonatal hyperammonemia in isovaleric acidemia

  2011cites this paper
• Akute metabolische Entgleisungen

  2011cites this paper
• N-carbamylglutamate Augments Ureagenesis and Reduces Ammonia and Glutamine in Propionic Acidemia

  2010cites this paper
• The Application of Clinical Genetics Dovepress N-acetylglutamate Synthase Deficiency: an Insight into the Genetics, Epidemiology, Pathophysiology, and Treatment

  year unknowncites this paper